北京 上海 天津 重庆 深圳 三亚 成都 南宁 济南 福州 长沙 银川 南京 赣州 武汉 昆明 杭州 沈阳 西安 合肥 南昌 厦门 鸡西 台州 苏州 青岛 泉州 珠海 地址：北京市朝阳区光华路正大中心北塔 11-12 层 邮编：100020 电话：01065876666 传真：01065876666-6 网址：www.zhongyinlawyer.com 二○二五年十月 北京中银律师事务所 关于晨光生物科技集团股份有限公司 2025 年第二次临时股东会之 法律意见书 晨光生物 2025 年第二次临时股东会·法律意见书 北京中银律师事务所 关于晨光生物科技集团股份有限公司 2025 年第二次临时股东会之法律意见书 致：晨光生物科技集团股份有限公司 北京中银律师事务所（以下称"本所"）接受晨光生物科技集团股份有限公 司（以下简称"公司"）的委托，根据《中华人民共和国公司法》等法律、法规、 规范性文件及《晨光生物科技集团股份有限公司章程》（以下简称"《公司章程》"） 的有关规定，就公司 2025 年第二次临时股东会（以下简称"本次股东会"）的 召集、召开程序、出席人员及召集人资格、大会表决程序、表决结果等事宜，出 ...

Core Insights - The agricultural processing sector saw a rise of 1.23% on October 10, with Guan Nong Co., Ltd. leading the gains [1] - The Shanghai Composite Index closed at 3897.03, down 0.94%, while the Shenzhen Component Index closed at 13355.42, down 2.7% [1] Agricultural Processing Sector Performance - Guan Nong Co., Ltd. (600251) closed at 9.18, up 7.24% with a trading volume of 351,800 shares and a turnover of 321 million yuan [1] - Dao Dao Quan (002852) closed at 11.61, up 5.55% with a trading volume of 183,100 shares and a turnover of 210 million yuan [1] - ST Zhongji (000972) closed at 3.65, up 4.89% with a trading volume of 95,700 shares and a turnover of 34.51 million yuan [1] - Other notable performers include Shuangta Food (002481) up 3.95%, Chenguang Biological (300138) up 3.60%, and Oufu Egg Industry (920371) up 2.81% [1] Capital Flow Analysis - The agricultural processing sector experienced a net outflow of 64.89 million yuan from institutional investors, while retail investors saw a net inflow of 40.97 million yuan [2] - The overall capital flow indicates a mixed sentiment, with institutional investors withdrawing funds while retail investors are actively buying [2] Individual Stock Capital Flow - Jinlongyu (300999) had a net outflow of 18.95 million yuan from institutional investors, while retail investors contributed a net inflow of 26.36 million yuan [3] - Jin Jian Rice Industry (600127) saw a net inflow of 4.54 million yuan from institutional investors, but a net outflow from retail investors [3] - ST Zhongji (000972) had a net inflow of 4.21 million yuan from institutional investors, indicating some positive sentiment despite overall sector outflows [3]

证券代码：300138 证券简称：晨光生物 公告编号：2025—105 晨光生物科技集团股份有限公司 现场会议召开时间：2025 年 10 月 10 日下午 14:40。 关于召开 2025 年第二次临时股东会的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 晨光生物科技集团股份有限公司（简称"公司"）于 2025 年 9 月 23 日在巨 潮资讯网（www.cninfo.com.cn）发布了《关于召开 2025 年第二次临时股东会的 通知》的公告，本次股东会采取现场投票与网络投票相结合的方式召开。 现将公司 2025 年第二次临时股东会的有关安排再次提示如下： 一、本次股东会召开的基本情况 1、股东会届次：2025 年第二次临时股东会 2、会议召集人：公司董事会，本次股东会的召开已经公司第五届董事会第 十九次会议审议通过。 3、会议召开的合法、合规性：本次股东会的召开符合《公司法》《上市公司 股东会规则》等有关法律法规、规范性文件和《公司章程》相关要求。 4、本次股东会召开的日期、时间 网络投票时间：通过深圳证券交易所交易系统进行网络投票的时间为 ...

证券代码：300138 证券简称：晨光生物 公告编号：2025—104 晨光生物科技集团股份有限公司 关于为子公司银行借款提供担保的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、担保情况概述 晨光生物科技集团股份有限公司（简称"公司"）于 2025 年 4 月 3 日召开 第五届董事会第十五次会议、2025 年 5 月 6 日召开 2024 年年度股东大会，审议 通过了《关于公司与子公司或子公司之间融资担保的议案》，同意公司及合并报 表范围内各级子公司在2024年年度股东大会审议通过之日起至2025年年度股东 大会召开日，向融资机构申请办理各类融资业务余额不超 70 亿元；融资担保方 式涉及公司合并报表范围内各主体之间担保：公司向合并报表范围内各级子公司 或各级子公司之间融资担保余额不超过 25 亿元，其中：向子公司新疆晨光生物 科技股份有限公司（简称"新疆晨光"）及其合并报表范围内子公司提供担保的 余额不超过 20.5 亿元（含新疆晨光合并报表范围内各主体互相担保），向其他 子公司提供担保或其他子公司之间互相担保的余额不超过 4.5 亿元。公 ...

Group 1 - The core viewpoint of the news is that Morning Light Bio has seen a stock price increase of 5.07%, reaching 13.26 CNY per share, with a total market capitalization of 6.406 billion CNY [1] - Morning Light Bio, established on April 12, 2000, and listed on November 5, 2010, specializes in the research, production, and sales of natural plant extracts, including chili red pigment, lutein, chili oil resin, lycopene, and cottonseed protein [1] - The company's main business revenue composition is as follows: cottonseed-related business accounts for 48.25%, pigment/spice/nutritional and medicinal products account for 47.39%, and others account for 4.35% [1] Group 2 - From the perspective of fund holdings, one fund under China Europe Fund has a significant position in Morning Light Bio, with the China Europe Value Selection Mixed A Fund holding 581,300 shares, representing 2.43% of the fund's net value [2] - The China Europe Value Selection Mixed A Fund has achieved a year-to-date return of 22.87% and a one-year return of 39.76%, ranking 4202 out of 8171 and 3898 out of 8004 respectively [2] - The fund manager, Zhang Xueming, has been in position for 1 year and 157 days, with the fund's total asset size at 1.711 billion CNY and the best return during his tenure being 70.87% [3]

Core Viewpoint - On September 25, no A-share listed companies disclosed any increase in shareholding, while 16 companies announced share reductions, indicating a trend of shareholder divestment in the market [1]. Summary by Category Share Reduction Details - Hanghua Co. plans to reduce up to 4.24 million shares of repurchased stock to supplement working capital [2] - Weili Sealing's shareholders plan to reduce up to 1% of the company's shares [2] - Milkewei's actual controller and shareholders intend to collectively reduce up to 4.02% of the company's shares [2] - Zhichun Technology's controlling shareholder reduced 4.2678 million shares on September 25 [2] - Xinao Micro's senior management plans to reduce up to 0.0134% of the company's shares [2] - Quanfeng Technology's Hesheng Health Insurance reduced 57.1419 million shares from September 22 to September 24 [2] - Morning Light Biological's senior management Li Fengfei plans to reduce up to 140,000 shares [2] - Everbright Jiabao's Jiading Jianye and Jiading Keti plan to reduce up to 1% of their shares [2] - Shengshi Technology's employee stock ownership platform plans to reduce up to 3% of the company's shares [2] - Xingsen Technology's actual controller Qiu Xingya reduced a total of 9.9639 million shares from August 5 to September 22 [2] - Haizheng Materials' Sinopec Capital plans to reduce up to 2.0267 million shares, accounting for 1% of the total share capital [2] - Zhengzhong Design's controlling shareholder plans to reduce up to 3% of the company's shares [2] - Baiya Co.'s three shareholders plan to collectively reduce up to 2% of the company's shares [2] - Jialiqi's shareholders plan to collectively reduce up to 3% of the company's shares [2] - Defu Technology's shareholders plan to collectively reduce up to 0.13% of the company's shares [2] - Jinyinhe's shareholders plan to reduce up to 0.35% of the company's total share capital [2] Market Signal - The MACD golden cross signal has formed, indicating a positive trend for certain stocks [1]

Core Viewpoint - Morning Light Bio (300138.SZ) announced that senior executive Li Fengfei plans to reduce his shareholding by 140,000 shares, representing 0.03% of the company's total share capital, within three months starting from October 27, 2025, through centralized bidding or block trading [1] Summary by Category - **Company Actions** - Li Fengfei intends to sell 140,000 shares of Morning Light Bio [1] - The reduction will occur within a specified period from October 27, 2025, to January 26, 2026 [1] - **Shareholding Impact** - The planned sale accounts for 0.03% of the total share capital of the company [1]

Core Points - Senior management personnel of Morning Light Biotechnology Group Co., Ltd. plan to reduce their shareholdings, specifically Li Fengfei [1] Summary by Sections Reduction Plan Details - Li Fengfei holds 567,883 shares of Morning Light, accounting for 0.12% of the total share capital. The planned reduction involves selling 140,000 shares, representing 0.03% of the total share capital, between October 27, 2025, and January 26, 2026, through centralized bidding or block trading. The reason for the reduction is personal financial needs, with shares sourced from pre-IPO issuance and stock incentive plans. The selling price will be determined based on market conditions at the time of sale [2] Commitment and Compliance - During the IPO, Li Fengfei made a commitment to limit share transfers to no more than 25% of his total holdings annually while in office, and no transfers for six months post-departure. After six months, transfers are limited to 50% of total holdings within the following year. As of the announcement date, Li Fengfei has adhered to these commitments without violations. The planned reduction aligns with previously disclosed intentions and commitments, and there are no circumstances preventing the reduction as per the Shenzhen Stock Exchange regulations [3]

晨光生物公告，持股56.79万股（占0.12%）的高级管理人员李凤飞计划自2025年10月27日至2026年1月 26日，通过集中竞价或大宗交易方式减持公司股份不超过14万股，占公司总股本0.03%。 ...

证券代码：300138 证券简称：晨光生物 公告编号：2025—103 晨光生物科技集团股份有限公司 关于高级管理人员减持股份的预披露公告 高级管理人员李凤飞保证向本公司提供的信息内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。本公司及董事会全体成员保证公告内容与信 息披露义务人提供的信息一致。 特别提示：持有本公司股份 567,883 股（占本公司总股本比例 0.12%）的高 级管理人员李凤飞计划于本公告披露日起 15 个交易日后的 3 个月内（即 2025 年 10 月 27 日至 2026 年 1 月 26 日），以集中竞价或大宗交易方式减持公司股份 140,000 股（占本公司总股本比例 0.03%）。 公司于近日收到公司高级管理人员李凤飞出具的《股票交易计划》，根据《上 市公司股东减持股份管理暂行办法》《上市公司董事和高级管理人员所持本公司 股份及其变动管理规则》《深圳证券交易所上市公司自律监管指引第 18 号—— 股东及董事、高级管理人员减持股份》等有关规定，现将相关情况公告如下： 一、拟减持股东的基本情况 （一）减持主体的名称：李凤飞 （二）减持主体持有股份的总数量、占公司总股本的比 ...